MILBEMYCIN OXIME PRAZIQUANTEL ALFAMED 16 MG / 40 MG FILM COATED TABLETS FOR CATS
MILBEMYCIN OXIME PRAZIQUANTEL ALFAMED 16 MG / 40 MG FILM COATED TABLETS FOR CATS
Authorised
- Milbemycin oxime
- Praziquantel
Product identification
Medicine name:
MILBEMYCIN OXIME PRAZIQUANTEL ALFAMED 16 MG / 40 MG FILM COATED TABLETS FOR CATS
Milbemycinoxim/Praziquantel "Alfamed" 16+40 mg filmovertrukne tabletter
Active substance:
- Milbemycin oxime
- Praziquantel
Target species:
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Milbemycin oxime16.00/milligram(s)1.00Tablet
-
Praziquantel40.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Film-coated tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AB51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Denmark
Package description:
- 1 box of 24 blisters containing 12 blisters of 2 tablets (divisible per tablet).
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application - change in active substance(s) (Article 19(1)(a) of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Alfamed
Marketing authorisation date:
Manufacturing sites for batch release:
- Alfamed
- Virbac France
Responsible authority:
- Danish Medicines Agency
Authorisation number:
- 70343
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0478/002
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
Germany
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Norway
-
Poland
-
Portugal
-
Slovakia
-
Spain
-
Sweden
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Danish (PDF)
Published on: 7/04/2025